Citations

Clear

382 citation(s) found for "Li, Man".

Mood‐Stabilizing Antiepileptic Treatment Response in Bipolar Disorder: A Genome‐Wide Association Study
Ho, Ada Man‐Choi , Coombes, Brandon J. , Nguyen, Thanh Thanh L. , Liu, Duan , Singh, Balwinder , Nassan, Malik , Colby, Colin , Weinshilboum, Richard M. , Frye, Mark A. , Colby, Colin L., Larrabee, Beth R. , Nguyen, Thanh Thanh L. , Ho, Ada M-C , Singh, Balwinder , Coombes, Brandon J , Liu, Duan , McElroy, Susan L. , Weinshilboum, Richard M. , Biernacka, Joanna M.

Mayo Clinic

Clinical Pharmacology & Therapeutics | July 6, 2020 | Volume: 108 | Issue: 6 | Pages: 1233-1242

10.1002/cpt.1982 | PMID 32627186 Get It

Several antiepileptic drugs (AEDs) have US Food and Drug Administration (FDA) approval for use as mood stabilizers in bipolar disorder (BD), but not all BD patients respond to these AED mood stabilizers (AED‐MSs). To identify genetic polymorphisms that contribute to the variability in AED‐MS response, we performed a discovery genome‐wide association study (GWAS) of 199 BD patients from the Mayo Clinic Bipolar Disorder Biobank. Most of these patients had been treated with the AED‐MS valproate/divalproex and/or lamotrigine. AED‐MS response was assessed using the Alda scale, which quantifies clinical improvement while accounting for potential confounding factors. We identified two genome‐wide significant single‐nucleotide polymorphism (SNP) signals that mapped to the THSD7A (rs78835388, P = 7.1E‐09) and SLC35F3 (rs114872993, P = 3.2E‐08) genes. We also identified two genes with statistically significant gene‐level associations: ABCC1 (P = 6.7E‐07; top SNP rs875740, P = 2.0E‐6), and DISP1 (P = 8.9E‐07; top SNP rs34701716, P = 8.9E‐07). THSD7A SNPs were previously found to be associated with risk for several psychiatric disorders, including BD. Both THSD7A and SLC35F3 are expressed in excitatory/glutamatergic and inhibitory/γ‐aminobutyric acidergic (GABAergic) neurons, which are targets of AED‐MSs. ABCC1 is involved in the transport of valproate and lamotrigine metabolites, and the SNPs in ABCC1 and DISP1 with the strongest evidence of association in our GWAS are strong splicing quantitative trait loci in the human gut, suggesting a possible influence on drug absorption. In conclusion, our pharmacogenomic study identified novel genetic loci that appear to contribute to AED‐MS treatment response, and may facilitate precision medicine in BD.
Editorial: no man’s oesophagus is an island
Katzka, David A. , Ravi, Karthik

Mayo Clinic

Alimentary Pharmacology & Therapeutics | June 27, 2020 | Volume: 52 | Issue: 2 | Pages: 395-396

10.1111/apt.15799 | PMID 32592254 Get It

LINKED CONTENTThis article is linked to Moosavi et al and Liwinski and Shcramm papers. To view these articles, visit https://doi.org/10.1111/apt.15758 and https://doi.org/10.1111/apt.15831.
80-year-old man with dyspnoea and bilateral groundglass infiltrates: an elusive case of COVID-19
Samec, Matthew J. , Khawaja, Ali , Patel, Ashokakumar M., Dugani, Sagar B. , Dugani, Sagar B

Mayo Clinic

BMJ Case Reports | May 28, 2020 | Volume: 13 | Issue: 5 | Pages: e236069

10.1136/bcr-2020-236069 | PMID 32467124 Get It

COVID-19 is a novel viral infection caused by severe acute respiratory syndrome-coronavirus-2 virus, first identified in Wuhan, China in December 2019. COVID-19 has spread rapidly and is now considered a global pandemic. We present a case of a patient with minimal respiratory symptoms but prominent bilateral groundglass opacities in a ‘crazy paving’ pattern on chest CT imaging and a negative initial infectious workup. However, given persistent dyspnoea and labs suggestive of COVID-19 infection, the patient remained hospitalised for further monitoring. Forty-eight hours after initial testing, the PCR test was repeated and returned positive for COVID-19. This case illustrates the importance of clinical vigilance to retest patients for COVID-19, particularly in the absence of another compelling aetiology. As COVID-19 testing improves to rapidly generate results, selective retesting of patients may uncover additional COVID-19 cases and strengthen measures to minimise the spread of COVID-19.
Solitary leg nodule in a young, physically active man
Swanson, Leah A. , Nelson, Steven A. , DiCaudo, David J.

Mayo Clinic

International Journal of Dermatology | April 20, 2020 | Volume: 59 | Issue: 10 | Pages: No page available

10.1111/ijd.14877 | PMID 32307708 Get It

Liver Transplantation for Cholangiocarcinoma and Mixed Hepatocellular Cholangiocarcinoma: Working Group Report From the ILTS Transplant Oncology Consensus Conference
Javle, Milind , Lerut, Jan , Ghobrial, R. Mark , Hibi, Taizo , Kwan, Nancy Man, Achilonu, Conrad Chibunna , Achilonu, Conrad C , Sapisochín, Gonzalo , Ohtsuka, Masayuki , Heimbach, Julie K.

Mayo Clinic

Transplantation | March 26, 2020 | Volume: 104 | Issue: 6 | Pages: 1125-1130

10.1097/tp.0000000000003212 | PMID 32217937 Get It

Liver transplantation for cholangiocarcinoma has been an absolute contraindication worldwide due to poor results. However, in recent years and thanks to improvements of patient management and treatments of this cancer, this indication has been revisited. This consensus paper, approved by the International Liver Transplant Society, aims to provide a collection of expert opinions, consensus, and best practices surrounding liver transplantation for cholangiocarcinoma.
Diabetes-associated genetic variation in TCF7L2 alters pulsatile insulin secretion in humans
LAURENTI, MARCELLO C. , Man, Chiara Dalla , Varghese, Ron T. , Andrews, James C. , Rizza, Robert A., Matveyenko, Aleksey V. , Nicolao, Giuseppe De , Vella, Adrian , Matveyenko, Aleksey, Vella, Adrian , Dalla Man, Chiara , Cobelli, Claudio

Mayo Clinic

JCI Insight | March 17, 2020 | Volume: 5 | Issue: 7 | Pages: No page available

10.1172/jci.insight.136136 | PMID 32182220 Get It

BACKGROUND Metabolic disorders such as type 2 diabetes have been associated with a decrease in insulin pulse frequency and amplitude. We hypothesized that the T allele at rs7903146 in TCF7L2, previously associated with β cell dysfunction, would be associated with changes in these insulin pulse characteristics. METHODS Twenty-nine nondiabetic subjects (age 46 ± 2, BMI 28 ± 1 kg/m 2 ) participated in this study. Of these, 16 were homozygous for the C allele at rs7903146 and 13 were homozygous for the T allele. Deconvolution of peripheral C-peptide concentrations allowed the reconstruction of portal insulin secretion over time. These data were used for subsequent analyses. Pulse orderliness was assessed by approximate entropy (ApEn), and the dispersion of insulin pulses was measured by a frequency dispersion index (FDI) after a Fast Fourier Transform (FFT) of individual insulin secretion rates. RESULTS During fasting conditions, the CC genotype group exhibited decreased pulse disorderliness compared with the TT genotype group (1.10 ± 0.03 vs. 1.19 ± 0.04, P = 0.03). FDI decreased in response to hyperglycemia in the CC genotype group, perhaps reflecting less entrainment of insulin secretion during fasting. CONCLUSION Diabetes-associated variation in TCF7L2 is associated with decreased orderliness and pulse dispersion, unchanged by hyperglycemia. Quantification of ApEn and FDI could represent novel markers of β cell health. FUNDING This work was funded by US NIH (DK78646, DK116231), University of Padova research grant CPDA145405, and Mayo Clinic General Clinical Research Center (UL1 TR000135).
Profound intellectual disability caused by homozygous TRAPPC9 pathogenic variant in a man from Malta
Wilton, Katelynn M. , Gunderson, Lauren, Hasadsri, Linda , Wood, Christopher P. , Schimmenti, Lisa A. , Gunderson, Lauren B, Schimmenti, Lisa A

Mayo Clinic

Molecular Genetics & Genomic Medicine | March 12, 2020 | Volume: 8 | Issue: 5 | Pages: No page available

10.1002/mgg3.1211 | PMID 32162493 Get It

AbstractBackgroundIntellectual disability is a complex multi‐faceted condition with diverse underlying etiologies. One rare form of intellectual disability is secondary to the loss of TRAPPC9, an activator of NF‐κB and a mediator of intracellular protein processing and trafficking. TRAPPC9 deficiency has been described in 48 patients with more than 15 pathologic variants.MethodClinical evaluation, magnetic resonance imaging, and whole‐exome sequencing were used to characterize the underlying cause of absent speech, restricted/repetitive behaviors, and worsening behavioral outbursts in 27‐year‐old man from Malta.ResultsMagnetic Resonance Imaging showed morphologic abnormalities, including global cerebral and cerebellar hypoplasia. Genetic analysis through Whole Exome Sequencing identified a homozygous deletion (c.568_574del) in TRAPPC9 resulting in a frameshift, premature stop codon, and ultimately a truncated protein (p.Trp190Argfs*95). In this case, the pathogenic variant was homozygous, identified in both of the parents without known consanguinity.ConclusionGiven the phenotype and genotype consistent with a deficiency in TRAPPC9, it is likely that this patient represents a novel case of this rare genetic syndrome. Specifically, this case, in the context of 48 total reported patients, raises questions as to the geographic origin of the pathologic variant and optimal detection and therapeutic intervention for this condition.
Differential Dorsolateral Prefrontal Cortex Proteomic Profiles of Suicide Victims with Mood Disorders
Cabello-Arreola, Alejandra , Ho, Ada Man‐Choi , Özerdem, Ayşegül , Cuéllar‐Barboza, Alfredo B. , Küçüker, Mehmet Utku , Heppelmann, Carrie J. , Charlesworth, M. Cristine , Ceylan, Deniz , Stockmeier, Craig A. , Rajkowska, Grażyna , Frye, Mark A. , Choi, Doo‐Sup, Kucuker, Mehmet U, Ho, Ada M-C , Cuellar-Barboza, Alfredo , Ozerdem, Aysegul , Charlesworth, M. Cristine , Veldić, Marin , Ceylan, Deniz

Mayo Clinic

Genes | March 2, 2020 | Volume: 11 | Issue: 3 | Pages: 256

10.3390/genes11030256 | PMID 32120974 Get It

Suicide is a major public health concern; nevertheless, its neurobiology remains unknown. An area of interest in suicide research is the dorsolateral prefrontal cortex (DLPFC). We aimed to identify altered proteins and potential biological pathways in the DLPFC of individuals who died by suicide employing mass spectrometry-based untargeted proteomics. Postmortem DLPFC from age-matched male suicide mood disorder cases (n = 5) and non-suicide mood disorder cases (n = 5) were compared. The proteins that differed between groups at false discovery rate (FDR) adjusted p-values (Benjamini–Hochberg–Yekutieli) <0.3 and Log2 fold change (FC) >|0.4| were considered statistically significant and were subjected to pathway analysis by Qiagen Ingenuity software. Thirty-three of the 5162 detected proteins showed significantly altered expression levels in the suicide cases and two of them after adjustment for body mass index. The top differentially expressed protein was potassium voltage-gated channel subfamily Q member 3 (KCNQ3) (Log2FC = −0.481, p = 2.10 × 10−09, FDR = 5.93 × 10−06), which also showed a trend to downregulation in Western blot (p = 0.045, Bonferroni adjusted p = 0.090). The most notably enriched pathway was the GABA receptor signaling pathway (p < 0.001). Here, we report a reduction trend of KCNQ3 levels in the DLPFC of male suicide victims with mood disorders. Further studies with a larger sample size and equal sex representation are needed.
Commentary on An Elderly Man with Dementia
Mills, John R.

Mayo Clinic

Clinical Chemistry | February 28, 2020 | Volume: 66 | Issue: 3 | Pages: 415-420

10.1093/clinchem/hvz018 | PMID 32109300 Get It

Clinical Reasoning: A 70-year-old man with rapid stepwise paraparesis and sensory loss
Krause, Monica , English, Stephen , Zalewski, Nicholas L. , Krause, Monica A, English, Stephen W

Mayo Clinic

Neurology | January 29, 2020 | Volume: 94 | Issue: 6 | Pages: No page available

10.1212/wnl.0000000000008925 | PMID 31992685 Get It